ABOUT CELYAD ONCOLOGY
Celyad Oncology is a biotechnology company focused on the research and discovery of chimeric antigen receptor (CAR) T-cell therapies for cancer.
Latest News
Our SCIENCE
At Celyad Oncology, we are pursuing next-generation cellular immunotherapies by applying our broad understanding of immunology, novel technology platforms and modular design approach to drug discovery.
Novel CAR T-cell Immunotherapies
Advancing both allogeneic and autologous CAR T-cell therapy candidates for the treatment of cancer
Stay informed about the latest news!
Sign up FOR our newsletter
By clicking on “send”, you consent that your personal data will be processed by us in order to send you our newsletter. You have the right to access, rectify, erase your data, to restrict the processing and the right to withdraw your consent at any time. You can find more information on how we process your data in our Privacy Policy.
